| Sirolimus for Kaposi's sarcoma in renal-transplant recipients G Stallone, A Schena, B Infante, S Di Paolo, A Loverre, G Maggio, ... New England Journal of Medicine 352 (13), 1317-1323, 2005 | 1129 | 2005 |
| Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation JM Campistol, J Eris, R Oberbauer, P Friend, B Hutchison, JM Morales, ... Journal of the American Society of Nephrology 17 (2), 581-589, 2006 | 596 | 2006 |
| Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation R Oberbauer, G Segoloni, JM Campistol, H Kreis, A Mota, J Lawen, ... Transplantation 78 (2), 30, 2004 | 282 | 2004 |
| Acute kidney injury in SARS-CoV-2 infected patients V Fanelli, M Fiorentino, V Cantaluppi, L Gesualdo, G Stallone, C Ronco, ... Critical Care 24, 1-3, 2020 | 236 | 2020 |
| Primary renal lymphoma does exist: case report and review of the literature. G Stallone, B Infante, C Manno, N Campobasso, G Pannarale, FP Schena Journal of nephrology 13 (5), 367-372, 2000 | 219 | 2000 |
| The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant M Rendina, A Schena, NM Castellaneta, F Losito, AC Amoruso, ... Journal of hepatology 46 (5), 768-774, 2007 | 187 | 2007 |
| MONOCYTE CHEMOTACTIC PEPTIDE-1 EXPRESSION AND MONOCYTE INFILTRATION IN ACUTE RENAL TRANSPLANT REJECTION1 G Grandaliano, L Gesualdo, E Ranieri, R Monno, G Stallone, FP Schena Transplantation 63 (3), 414-420, 1997 | 176 | 1997 |
| Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients G Stallone, B Infante, A Schena, M Battaglia, P Ditonno, A Loverre, ... Journal of the American Society of Nephrology 16 (12), 3755-3762, 2005 | 156 | 2005 |
| Management of side effects of sirolimus therapy G Stallone, B Infante, G Grandaliano, L Gesualdo Transplantation 87 (8S), S23-S26, 2009 | 153 | 2009 |
| The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review F Rascio, F Spadaccino, MT Rocchetti, G Castellano, G Stallone, GS Netti, ... Cancers 13 (16), 3949, 2021 | 151 | 2021 |
| Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses C Procaccini, V De Rosa, M Galgani, F Carbone, S Cassano, D Greco, ... The Journal of Immunology 189 (6), 2941-2953, 2012 | 141 | 2012 |
| The use of immune checkpoint inhibitors in oncology and the occurrence of AKI: where do we stand? R Franzin, GS Netti, F Spadaccino, C Porta, L Gesualdo, G Stallone, ... Frontiers in immunology 11, 574271, 2020 | 137 | 2020 |
| Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin A Loverre, P Ditonno, A Crovace, L Gesualdo, E Ranieri, P Pontrelli, ... Journal of the American Society of Nephrology 15 (10), 2675-2686, 2004 | 118 | 2004 |
| INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS: Role of Growth Factors and Cytokines: 1 LF Morrone, S Di Paolo, F Logoluso, A Schena, G Stallone, F Giorgino, ... Transplantation 64 (6), 913-918, 1997 | 115 | 1997 |
| Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and … S Di Paolo, A Schena, LF Morrone, G Manfredi, G Stallone, C Derosa, ... Transplantation 69 (10), 2049-2054, 2000 | 113 | 2000 |
| Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients G Stallone, S Di Paolo, A Schena, B Infante, G Grandaliano, M Battaglia, ... Transplantation 75 (7), 998-1003, 2003 | 106 | 2003 |
| Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer G Stallone, L Cormio, GS Netti, B Infante, O Selvaggio, GD Fino, E Ranieri, ... Cancer research 74 (16), 4230-4238, 2014 | 104 | 2014 |
| Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function G Stallone, S Di Paolo, A Schena, B Infante, M Battaglia, P Ditonno, ... Journal of the American Society of Nephrology 15 (1), 228-233, 2004 | 103 | 2004 |
| Sirolimus interferes with iron homeostasis in renal transplant recipients A Maiorano, G Stallone, A Schena, B Infante, P Pontrelli, FP Schena, ... Transplantation 82 (7), 908-912, 2006 | 95 | 2006 |
| PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma GS Netti, G Lucarelli, F Spadaccino, G Castellano, M Gigante, C Divella, ... Aging (Albany NY) 12 (8), 7585, 2020 | 87 | 2020 |
